Artículos del autor

solaci

Events

Opportunity for Fellows! 1 Year Training Program from McMaster University (Canada) – SOLACI Invitation

McMaster University in Canada, is developing a 1-year training program on imaging guided percutaneous coronary intervention (non-invasive...
solaci -
Structural heart disease

TAVR Durability at 5 Years in Intermediate Risk Patients

TAVR has been shown beneficial in patients across the risk spectrum. The PARTNER 2 SAPIEN 3 (P2S3i)...
solaci -
Institutional News

Dominican Republic Regional Sessions 2023: Young Interventionists Contest is Still Open

Submissions to take part in the Contest for Young Interventional Cardiologists at the Dominican Republic Sessions 2023 is still...
solaci -
Mitral valve

Is Edge-to-Edge Treatment with PASCAL Effective at 3 Years?

Mitral regurgitation is the most common valvular heart disease. Its cause is most frequently functional or secondary...
solaci -
Institutional News

Meet the international faculties of SOLACI-SBHCI 2023 Congress

Meet the opinion leaders from around the world who will attend the SOLACI-SBHCI 2023 congress See the Full...
solaci -
Coronary disease

Relationship between Distal Vessel Quality and Outcomes in the Treatment of Chronic Total Occlusions

Percutaneous treatment of chronic total occlusions has increase, and has become a a more habitual therapeutic challenge....
solaci -
Mitral valve

Cerebrovascular Events in the COAPT Study

Transcatheter edge-to-edge repair (TEER) with MitraClip has demonstrated its benefit compared with complete guideline-directed medical therapy (GDMT),...
solaci -
Structural heart disease

Transcatheter Mitral Valve Replacement vs. Medical Therapy

Mitral valve regurgitation (MR) is a common cause behind heart failure and is associated to hospitalization for...
solaci -